| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | K1M5RVL18S |
Structure
| InChI Key | ZXRVKCBLGJOCEE-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C6H8N2O2 |
| Molecular Weight | 140.14 |
| AlogP | 0.03 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 58.29 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 10.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | ||
|
Ion channel
Ligand-gated ion channel
GABA-A receptor
|
14000-14125 | 32-130 | - | 160 | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sleep Initiation and Maintenance Disorders | 3 | D007319 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Angelman Syndrome | 2 | D017204 | ClinicalTrials |
| Fragile X Syndrome | 2 | D005600 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 64603-91-4 |
| ChEBI | 34373 |
| ChEMBL | CHEMBL312443 |
| DrugBank | DB06554 |
| EPA CompTox | DTXSID0045206 |
| FDA SRS | K1M5RVL18S |
| Guide to Pharmacology | 4322 |
| KEGG | C13693 |
| PubChem | 3448 |
| SureChEMBL | SCHEMBL247815 |
| ZINC | ZINC000019795995 |
CONTENTS